Global Antibody Production Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • ID: 4489580
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
This Analysis Estimates that the Global Antibody Production Market is Anticipated to Grow at a CAGR of 12.4 %

FEATURED COMPANIES

  • Abbott Laboratories (U.S)
  • Abcam Plc(United Kingdom)
  • Cellab Gmbh(Germany)
  • Eppendorf Ag (Germany)
  • GE Healthcare (US)
  • Gene Tex(U.S)
  • MORE

Antibodies are host proteins that are generated by the immune system to respond the foreign molecules that enter the body. This analysis estimates that the global antibody production market is anticipated to grow at a CAGR of 12.4 % during the forecasted period. The key trend which is positively influencing the growth of antibody production market is increasing funding from government and private organizations for research activities. Increasing R&D expenditure in pharmaceuticals by biotechnology companies and improved approval rate of therapeutic antibodies by regulatory authorities majorly contributes to the growth of the global connected mining market during the forecast period.

However, cost constraint related to the adoption of membrane filter is the factor that restrains the growth of the global connected mining market during the forecast period. Further, the key opportunities for the global antibody production market are increasing risk of infectious diseases and rising demand for protein therapeutics, these are the factors which will help to grow the global antibody production market.

The global angiography devices market is led by North America as it attained major market share in 2016. In North America region, U.S and Canada are the largest market shareholders.  In the U.S., rising incidences of cancer, increased government funding for medical research and technological advancements will drive the antibody production market. Moreover, in Canada, regulatory approvals, authorizations for use of monoclonal antibodies, and the need for quality cancer treatment are likely to boost the antibody production market. Further, Asia-Pacific is expected to be the fastest growing region.

The growth in the global antibody production market is also influenced by the presence of major market players such as GE Healthcare (United States), ThermoFisher Scientific, Inc (United States), Pall Corporation (United States), Fiber- Cell Systems Inc (United States), Sigma-Aldrich Corporation (Germany), Sartorius AG (Germany) and Merck KGaA (Germany). To gain competitive advantage the major players adopt strategies such as mergers & acquisitions, joint ventures etc.

The antibody production market is mainly classified on the basis of process and end users. The process segment of the antibody production market includes upstream processing, downstream processing and filtration. On the basis of end-user, the market is bifurcated into research institutes, pharmaceutical and biotechnology companies and diagnostics laboratories of which pharmaceutical and biotechnology companies dominates the antibody production market and anticipated to register the highest CAGR during the forecast period of 2016-2023.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories (U.S)
  • Abcam Plc(United Kingdom)
  • Cellab Gmbh(Germany)
  • Eppendorf Ag (Germany)
  • GE Healthcare (US)
  • Gene Tex(U.S)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Antibody Production Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Adoption Of Targeted Immunotherapy
3.1.2. Increasing R&D Expenditure In Pharmaceuticals By Biotechnological Companies
3.1.3. Rising Number Of Fast Track And Orphan Drug Destinations
3.1.4. Improved Approval Rate Of Therapeutic Antibodies By Regulatory Authorities
3.2. Market Restraints
3.2.1. Cost Constraints Related To The Adoption Of Membrane Filters
3.3. Market Opportunities
3.3.1. Rising Demand For Protein Therapeutics
3.3.2. Increasing Risk Of Infectious Diseases
3.4.  Market Challenges
3.4.1. High Cost Of Primary Antibodies

4. Market Segmentation
4.1. Global Antibody Production Market By Process
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4.  Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Upstream Processing Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Downstream Processingmarket
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global  Filtration Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Key Players & Key Products
4.1.5.3.4. Key Conclusions
4.2. Global Antibody Production Market By End-User
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Pharmaceuticals And Biotechnology Companies Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Diagnostics Laboratories Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.2.5.3. Global Research Institutes Market
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.3. Key Players & Key Products
4.2.5.3.4. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List Of Mergers And Acquisition
5.1.2. List Of Joint Ventures
5.1.3. List Of Product Launches
5.1.4. List Of Partnerships

6. Geographic Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Antibody Production Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. UK
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest Of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key  Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key  Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest Of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key  Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Abcam Plc(United Kingdom)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Abbott Laboratories (U.S)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Cellab Gmbh(Germany)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Eppendorf Ag (Germany)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Fibercell Systems Inc. (Us)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Ge Healthcare (Us)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Gene Tex(U.S)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Integra Biosciences Ag (Switzerland)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Merck Millipore (Germany)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Pall Corporation(Us)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Roche Diagnostics Corporation (United States)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Sartorius Ag( Germany)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Sigma Aldrich Corporation(Germany)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Thermofisher Scientific Inc.(Us)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Genscript (U.S)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis

List Of Tables
1. Global Antibody Production Market Byprocess2014-2023 ($ Million)
2. Global Upstream Processing Market By Geography 2014-2023 ($ Million)
3. Global Downstream Processing Market By Geography 2014-2023 ($ Million)
4. Global  Filterationmarket By Geography 2014-2023 ($ Million)
5. Global Antibody Production Market Byend-Users2014-2023 ($ Million)
6. Global Pharmaceuticals  And Biotechnology Companies Market By Geography 2014-2023 ($ Million)
7. Global Diagnostics Laboratories Market By Geography 2014-2023 ($ Million)
8. Global Research Institutes Market By Geography 2014-2023 ($ Million)
9. North America Antibody Production Market 2014-2023 ($ Million)
10. Europe Antibody Production Market 2014-2023 ($ Million)
11. Asia Pacific Antibody Production Market 2014-2023 ($ Million)
12. Rest Of The World Antibody Production Market 2014-2023 ($ Million)

List Of Figures
1. Global Upstream Processing Market 2014-2023 ($ Million)
2. Global Downstream Processing Market 2014-2023 ($ Million)
3. Global Filteration Market  2014-2023 ($ Million)
4. Global Pharmaceuticals And Biotechnology Companies Market 2014-2023 ($ Million)
5. Global Diagnostics Laboratories Market   2014-2023 ($ Million)
6. Global Research Institutes Market   2014-2023 ($ Million)
7. United States (U.S.) Antibody Production Market 2014-2023 ($ Million)
8. Canada Antibody Production Market 2014-2023 ($ Million)
9. United Kingdom (UK) Antibody Production Market 2014-2023 ($ Million)
10. France Antibody Production Market 2014-2023 ($ Million)
11. Germany Antibody Production Market 2014-2023 ($ Million)
12. Spain Antibody Production Market 2014-2023 ($ Million)
13. Roe Antibody Production Market 2014-2023 ($ Million)
14. India Antibody Production Market 2014-2023 ($ Million)
15. China Antibody Production Market 2014-2023 ($ Million)
16. Japan Antibody Production Market 2014-2023 ($ Million)
17. Australia Antibody Production Market 2014-2023 ($ Million)
18. Roapac Antibody Production Market 2014-2023 ($ Million)
19. Latin America Antibody Production Market 2014-2023 ($ Million)
20. Mena Antibody Production Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories (U.S)
  • Abcam Plc(United Kingdom)
  • Cellab Gmbh(Germany)
  • Eppendorf Ag (Germany)
  • Fibercell Systems Inc. (US)
  • GE Healthcare (US)
  • Gene Tex(U.S)
  • Genscript (U.S)
  • Integra Biosciences Ag (Switzerland)
  • Merck Millipore (Germany)
  • Pall Corporation(US)
  • Roche Diagnostics Corporation (United States)
  • Sartorius Ag( Germany)
  • Sigma Aldrich Corporation(Germany)
  • Thermofisher Scientific Inc.(US)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll